PayerTalkCE

Chapter 2 of a 2-Part CE Podcast This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/multiple-myeloma-decision-tool/. As MM progresses to relapsed/refractory MM (RRMM), the selection of an appropriate treatment regimen becomes more complex, requiring an assessment of severity, risk, and prior lines of therapy. Newer agents such as chimeric antigen receptor (CAR) T-cell therapies or bispecific antibody therapies may be indicated

Chapter 1 of a 2-Part CE Podcast This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/multiple-myeloma-decision-tool/. As MM progresses to relapsed/refractory MM (RRMM), the selection of an appropriate treatment regimen becomes more complex, requiring an assessment of severity, risk, and prior lines of therapy. Newer agents such as chimeric antigen receptor (CAR) T-cell therapies or bispecific antibody therapies may be indicated

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/sclc-evolving-treatment-landscape. This activity will provide managed care professionals with a practical, evidence-based review of the evolving treatment landscape in extensive-stage small cell lung cancer (ES-SCLC), with a focus on how emerging clinical data can inform coverage policies, oncology pathways, and utilization management strategies. Participants will explore the

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/clearer-pathways. Given emerging evidence and recently updated clinical guidelines in the management of retinal diseases, managed care and payer professionals require competence to integrate emerging clinical trends and updates into the management of retinal diseases. There is a growing need for health care professionals to understand evidence-based care management strate

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/psoriasis-best-practices/. The psoriasis treatment landscape is rapidly evolving. Although treatment guidelines are routinely updated, ongoing innovation and the introduction of new therapies frequently render even the most current guidelines incomplete. During this podcast, managed care decision makers will expand their knowledge and learn about the importance of early interv

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://managedcareeye.com/preventing-blindness. This podcast will highlight challenges across the patient journey—including access to care, benefit design, and coverage decision-making—and their impact on timely diagnosis and treatment. The expert faculty will share payer perspectives on current coverage policies, care coordination, and system-level opportunities to support earlier intervention and ev